Lingyu Wei
East China University of Science and Technology(CN)Changzhi Medical College(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Immune cells in cancer, Viral-associated cancers and disorders, Epigenetics and DNA Methylation, Immune Response and Inflammation
Most-Cited Works
- → Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs(2017)116 cited
- → Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway(2017)115 cited
- → Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer(2022)103 cited
- → Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression(2018)95 cited
- → Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice(2017)94 cited
- → Phase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression(2020)85 cited
- → Sequentially Stimuli-Responsive Anticancer Nanomedicines(2021)81 cited
- → Polydopamine‐Decorated PLCL Conduit to Induce Synergetic Effect of Electrical Stimulation and Topological Morphology for Peripheral Nerve Regeneration(2023)70 cited
- → miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1(2016)69 cited
- → Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape(2020)58 cited